Pediatric Chronic Kidney Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Pediatrics Center of Excellence, Children's Medical Center, 62 Qarib St., Keshavarz Blvd, 14194, Tehran, Iran.
Pediatr Nephrol. 2022 Sep;37(9):2179-2183. doi: 10.1007/s00467-022-05449-w. Epub 2022 Feb 3.
Carnitine plays a crucial role in the metabolism of fatty acids as well as energy production. Previous research has suggested a significant decrease in carnitine levels in patients with kidney failure and those undergoing hemodialysis. Therefore, we designed this study to assess the prevalence and characteristics of carnitine deficiency and its association with hemodialysis complications in the pediatric population.
This research was a pilot study of 29 children undergoing hemodialysis. Before hemodialysis, a 5-mL blood sample was drawn from each patient through a peripheral vein to measure serum-free carnitine levels, complete blood count with differential, blood urea nitrogen (BUN), creatinine, and electrolytes. Each patient was observed for intradialytic complications, including muscle cramps and hypotension, during 12 sessions of hemodialysis.
We included 26 participants with a mean age of 14.23 years undergoing hemodialysis. Carnitine deficiency was revealed in 54.8% of our participants. Also, there was no significant correlation between carnitine deficiency and age, gender, and BUN levels (P = 0.698, P = 0.43, and P > 0.05, respectively). Intradialytic complications, including episodes of hypotension and muscle cramps, were more frequent in patients with carnitine deficiency (P = 0.02, P = 0.01, respectively). Other reasons for muscle cramps, such as fluid overload, nutritional status, dialysis regimen, and other important lab results (phosphorus, magnesium, etc.), were ruled out.
In conclusion, we found a higher prevalence of carnitine deficiency in pediatric hemodialysis patients. Carnitine deficiency was significantly associated with increased intradialytic symptoms, including muscle spasms and hypotension. Our results could support a potential role of carnitine supplementation in pediatric patients with kidney failure for controlling intradialytic complications, but this requires further investigation. A higher resolution version of the Graphical abstract is available as Supplementary information.
肉碱在脂肪酸代谢和能量产生中起着至关重要的作用。先前的研究表明,肾衰竭和接受血液透析的患者的肉碱水平显著下降。因此,我们设计了这项研究,以评估儿童人群中肉碱缺乏的患病率和特征及其与血液透析并发症的关系。
这是一项对 29 名接受血液透析的儿童进行的试点研究。在血液透析前,通过外周静脉从每位患者抽取 5 毫升血液样本,以测量游离肉碱水平、全血细胞计数、血尿素氮(BUN)、肌酐和电解质。在 12 次血液透析期间,观察每位患者是否出现透析中并发症,包括肌肉痉挛和低血压。
我们纳入了 26 名平均年龄为 14.23 岁的接受血液透析的参与者。我们的参与者中有 54.8%存在肉碱缺乏。此外,肉碱缺乏与年龄、性别和 BUN 水平之间没有显著相关性(P=0.698、P=0.43 和 P>0.05)。在肉碱缺乏的患者中,透析中并发症(包括低血压和肌肉痉挛发作)更为频繁(P=0.02、P=0.01)。排除了其他导致肌肉痉挛的原因,如液体超负荷、营养状况、透析方案和其他重要实验室结果(如磷、镁等)。
总之,我们发现儿科血液透析患者中肉碱缺乏的患病率较高。肉碱缺乏与透析中症状(包括肌肉痉挛和低血压)的增加显著相关。我们的结果可以支持在肾衰竭的儿科患者中补充肉碱以控制透析中并发症的潜在作用,但这需要进一步研究。高分辨率版本的图表摘要可在补充信息中查看。